NIH-funded research R01 grant

Investigating how glucose levels affect the risk of Alzheimer's disease

Official title: Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis

Funded at Medstar Health Research Institute · NIH-11261900 · Data updated 2026-11-12

This study is looking at how blood sugar levels might affect the risk of developing Alzheimer's and related memory problems, and it's for anyone interested in understanding how managing glucose could help protect their brain health.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedstar Health Research Institute
NIH-funded
Lab location1 site (Hyattsville, United States)
Project startSeptember 30, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$724,004
NIH project number7R01AG070881-03
Project IDNIH-11261900 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with varying glucose levels, particularly those at risk for type 2 diabetes or cognitive decline.

Less likely to help

Patients who do not have any glucose metabolism issues or those already diagnosed with advanced Alzheimer's disease may not benefit from this research.

What this research studies

This research explores the relationship between glucose homeostasis and the risk of developing Alzheimer's disease and related dementias. By examining a diverse group of participants from the Multi-Ethnic Study of Atherosclerosis, the study aims to identify how different glucose levels and dysglycemia may contribute to cognitive decline. The research will analyze neurocognitive markers to better understand the mechanisms linking glucose metabolism and Alzheimer's disease. This could provide insights into potential preventive strategies for at-risk individuals.

Why it matters

Potential benefit: If successful, this research could lead to new prevention strategies for Alzheimer's disease, particularly for individuals with glucose metabolism issues.

How similar studies have gone: Previous research has indicated a link between glucose metabolism and cognitive decline, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Medstar Health Research Institute
    Hyattsville, United States
    Active

Researchers

  • Principal investigator: Mongraw-Chaffin, Morgana Lee — Medstar Health Research Institute
  • Study coordinator: Mongraw-Chaffin, Morgana Lee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.